The University of Liverpool’s Department of Molecular and Clinical Pharmacology has been honoured with a Queen’s Anniversary Prize – one of the most prestigious awards in higher education – in recognition of its work to improve the safety and effectiveness of medicines.
The Department of Molecular and Clinical Pharmacology, which is one of the oldest and largest in the UK, has an international reputation for understanding all aspects of drug actions from designing and creating novel drugs, running clinical trials on new drugs, through to improving the use of existing drugs.
It leads the world in understanding, predicting, and tackling adverse drug reactions and has developed tools that are used globally by physicians to avoid adverse drug reactions in susceptible patients delivering huge impact in the care of millions of patients worldwide.
The Department has notable research expertise in personalised medicines, HIV drug safety, paediatric pharmacology, epilepsy therapy, cancer pharmacology, regenerative medicine’s safety, drug discovery, toxicology and drug safety, antimicrobial pharmacodynamics, and drug molecular nano-formulations.
Alongside a track record for training future leaders in the clinic, academia, and the pharmaceutical industry, the Department is consistently ranked as one of the UK’s top teaching schools for Pharmacology for both undergraduate and postgraduate students.
Professor David MacEwan, Head of the Department of Molecular and Clinical Pharmacology, said: “Since its inception, the Department’s expertise in pharmacological understanding has ensured that we have been one of the most highly regarded Pharmacology institutions in the UK.
“The resulting knowledge from our molecular and clinical research has had an enormous impact on the daily lives of people by not only developing new drugs and treatments, but identifying problems in existing treatments and circumventing side-effects in future therapies.
“Through our bench to bedside approach we continuously strive to ensure our work improves the development of medicines, for the benefit of society.
“It is a great honour to be awarded the Queen’s Anniversary Prize which recognises the excellent work carried out by our staff.”
The University’s Vice Chancellor, Professor Janet Beer, added: “The Queen’s Anniversary Prizes reward excellence in work of outstanding importance and quality in higher and further education, so this honour is real testament to the deep and far-reaching impact of research carried out by the Department of Molecular and Clinical Pharmacology here at Liverpool.”
The Queen’s Anniversary Prizes are administered by the Royal Anniversary Trust and presented every two years to reward innovative work of outstanding quality within the higher and further education sector.
The Prize will be officially presented to the University in February 2018 by a member of the royal family at a ceremony to be held at Buckingham Palace.
You must be logged in to post a comment.
All recent news
Event: Discover the Year in China with Professor David Goodman
Professor Kevin Park retires after a remarkable 51 years at the University
Student entrepreneurs encouraged to take part in the 2019 Liverpool Business Competition
€10M ERC Synergy Grant to discover new materials using intelligent robots
Exciting job opportunity: Work as a Student Social Media Ambassador
In partnership with the Uni of Southampton and Uni of Rostock, we’ve been awarded a €10 million ERC Synergy Grant to combine computational chemistry and robots to discover new materials #ERCSyG #materialscience https://t.co/MpyBkitlSN
Packed house for brilliant @LivUniArch #BrutalismNow event at our impressive @Liv_Uni_London campus in heart of the city. Angela Brady introducing "very important" session on post war buildings #Brutalism #architecture
Liver fluke - a harmful parasite that costs the UK cattle & sheep industry an estimated £300M each year - may also be an under‐recognised cause of liver disease in horses, a study by @IGHLiverpool reports https://t.co/wrBQtTiWDy